Schrodinger Inc

Change company Symbol lookup

Select an option...

SDGR Schrodinger Inc

SPLK Splunk Inc

TW Tradeweb Markets Inc

CMPGY Compass Group PLC

DZSI DZS Inc

FCPT Four Corners Property Trust Inc

UGI UGI Corp

BMI Badger Meter Inc

JKS JinkoSolar Holding Co Ltd

AGFY Agrify Corp

Go

Schrodinger, Inc. has developed a physics-based software platform, which enables discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions and government laboratories around the world. The Company also leverages its software platform to advance collaborative programs and its own pipeline of therapeutics to address unmet medical needs. The Company operates through two segments: software and drug discovery. The software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on building a portfolio of preclinical and clinical programs, internally and through collaborations, which has advanced to various stages of discovery and development. The Company’s pipeline of drug discovery programs include MALT1, CDC7, Wee1, and SOS1/KRAS.